List of IMMUNOMEDICS, INC. patents

Patents where

Current Assignee

Name

‌

IMMUNOMEDICS, INC.

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7563433 Methods and compositions for F-18 labeling of proteins, peptides and other molecules	Patent 7563433 was granted and assigned to IMMUNOMEDICS, INC. on July, 2009 by the United States Patent and Trademark Office.		‌ IMMUNOMEDICS, INC.	United States Patent and Trademark Office	7563433	July 21, 2009
‌ US Patent 8153101 Methods and compositions for F-18 labeling of proteins, peptides and other molecules	Patent 8153101 was granted and assigned to IMMUNOMEDICS, INC. on April, 2012 by the United States Patent and Trademark Office.		‌ IMMUNOMEDICS, INC.	United States Patent and Trademark Office	8153101	April 10, 2012
‌ US Patent 9475883 Therapeutic use of anti-CD22 antibodies for inducing trogocytosis	Patent 9475883 was granted and assigned to IMMUNOMEDICS, INC. on October, 2016 by the United States Patent and Trademark Office.	‌ IMMUNOMEDICS, INC.	‌ IMMUNOMEDICS, INC.	United States Patent and Trademark Office	9475883	October 25, 2016
‌ US Patent 7517964 RS7 antibodies	Patent 7517964 was granted and assigned to IMMUNOMEDICS, INC. on April, 2009 by the United States Patent and Trademark Office.		‌ IMMUNOMEDICS, INC.	United States Patent and Trademark Office	7517964	April 14, 2009
‌ US Patent 9757458 Crosslinking of CD22 by epratuzumab triggers BCR signaling and caspase-dependent apoptosis in hematopoietic cancer cells	Patent 9757458 was granted and assigned to IMMUNOMEDICS, INC. on September, 2017 by the United States Patent and Trademark Office.	‌ IMMUNOMEDICS, INC.	‌ IMMUNOMEDICS, INC.	United States Patent and Trademark Office	9757458	September 12, 2017
‌ US Patent 9238084 Anti-mucin antibodies for early detection and treatment of pancreatic cancer	Patent 9238084 was granted and assigned to IMMUNOMEDICS, INC. on January, 2016 by the United States Patent and Trademark Office.	‌ IMMUNOMEDICS, INC.	‌ IMMUNOMEDICS, INC.	United States Patent and Trademark Office	9238084	January 19, 2016
‌ US Patent 11541047 Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity	Patent 11541047 was granted and assigned to IMMUNOMEDICS, INC. on January, 2023 by the United States Patent and Trademark Office.	‌ IMMUNOMEDICS, INC.	‌ IMMUNOMEDICS, INC.	United States Patent and Trademark Office	11541047	January 3, 2023
‌ US Patent 7238785 RS7 antibodies	Patent 7238785 was granted and assigned to IMMUNOMEDICS, INC. on July, 2007 by the United States Patent and Trademark Office.		‌ IMMUNOMEDICS, INC.	United States Patent and Trademark Office	7238785	July 3, 2007
‌ US Patent 9770517 Anti-Trop-2 antibody-drug conjugates and uses thereof	Patent 9770517 was granted and assigned to IMMUNOMEDICS, INC. on September, 2017 by the United States Patent and Trademark Office.	‌ IMMUNOMEDICS, INC.	‌ IMMUNOMEDICS, INC.	United States Patent and Trademark Office	9770517	September 26, 2017
‌ US Patent 9745380 RS7 antibodies	Patent 9745380 was granted and assigned to IMMUNOMEDICS, INC. on August, 2017 by the United States Patent and Trademark Office.		‌ IMMUNOMEDICS, INC.	United States Patent and Trademark Office	9745380	August 29, 2017
‌ US Patent 8084583 RS7 antibodies	Patent 8084583 was granted and assigned to IMMUNOMEDICS, INC. on December, 2011 by the United States Patent and Trademark Office.		‌ IMMUNOMEDICS, INC.	United States Patent and Trademark Office	8084583	December 27, 2011
‌ US Patent 6953675 Landscaped antibodies and antibody fragments for clinical use	Patent 6953675 was granted and assigned to IMMUNOMEDICS, INC. on October, 2005 by the United States Patent and Trademark Office.		‌ IMMUNOMEDICS, INC.	United States Patent and Trademark Office	6953675	October 11, 2005
‌ US Patent 7537930 Mammalian cell lines for increasing longevity and protein yield from a cell culture	Patent 7537930 was granted and assigned to IMMUNOMEDICS, INC. on May, 2009 by the United States Patent and Trademark Office.		‌ IMMUNOMEDICS, INC.	United States Patent and Trademark Office	7537930	May 26, 2009
‌ US Patent 8491896 Anti-pancreatic cancer antibodies	Patent 8491896 was granted and assigned to IMMUNOMEDICS, INC. on July, 2013 by the United States Patent and Trademark Office.		‌ IMMUNOMEDICS, INC.	United States Patent and Trademark Office	8491896	July 23, 2013
‌ US Patent 7147856 Stable radioiodine conjugates and methods of their synthesis	Patent 7147856 was granted and assigned to IMMUNOMEDICS, INC. on December, 2006 by the United States Patent and Trademark Office.		‌ IMMUNOMEDICS, INC.	United States Patent and Trademark Office	7147856	December 12, 2006
‌ US Patent 9005613 Anti-mucin antibodies for early detection and treatment of pancreatic cancer	Patent 9005613 was granted and assigned to IMMUNOMEDICS, INC. on April, 2015 by the United States Patent and Trademark Office.	‌ IMMUNOMEDICS, INC.	‌ IMMUNOMEDICS, INC.	United States Patent and Trademark Office	9005613	April 14, 2015
‌ US Patent 7282567 Monoclonal antibody hPAM4	Patent 7282567 was granted and assigned to IMMUNOMEDICS, INC. on October, 2007 by the United States Patent and Trademark Office.		‌ IMMUNOMEDICS, INC.	United States Patent and Trademark Office	7282567	October 16, 2007
‌ US Patent 9707302 Combining anti-HLA-DR or anti-Trop-2 antibodies with microtubule inhibitors, PARP inhibitors, bruton kinase inhibitors or phosphoinositide 3-kinase inhibitors significantly improves therapeutic outcome in cancer	Patent 9707302 was granted and assigned to IMMUNOMEDICS, INC. on July, 2017 by the United States Patent and Trademark Office.	‌ IMMUNOMEDICS, INC.	‌ IMMUNOMEDICS, INC.	United States Patent and Trademark Office	9707302	July 18, 2017
‌ US Patent 7993626 Methods and compositions for F-18 labeling of proteins, peptides and other molecules	Patent 7993626 was granted and assigned to IMMUNOMEDICS, INC. on August, 2011 by the United States Patent and Trademark Office.		‌ IMMUNOMEDICS, INC.	United States Patent and Trademark Office	7993626	August 9, 2011
‌ US Patent 9683050 Stable compositions of high-concentration allotype-selected antibodies for small-volume administration	Patent 9683050 was granted and assigned to IMMUNOMEDICS, INC. on June, 2017 by the United States Patent and Trademark Office.	‌ IMMUNOMEDICS, INC.	‌ IMMUNOMEDICS, INC.	United States Patent and Trademark Office	9683050	June 20, 2017
‌ US Patent 9180205 Stable compositions of high-concentration allotype-selected antibodies for small-volume administration	Patent 9180205 was granted and assigned to IMMUNOMEDICS, INC. on November, 2015 by the United States Patent and Trademark Office.	‌ IMMUNOMEDICS, INC.	‌ IMMUNOMEDICS, INC.	United States Patent and Trademark Office	9180205	November 10, 2015
‌ US Patent 7837995 Immunotherapy of B-cell malignancies using anti-CD22 antibodies	Patent 7837995 was granted and assigned to IMMUNOMEDICS, INC. on November, 2010 by the United States Patent and Trademark Office.		‌ IMMUNOMEDICS, INC.	United States Patent and Trademark Office	7837995	November 23, 2010
‌ US Patent 10034950 Antibody-SN-38 immunoconjugates with a CL2A linker	Patent 10034950 was granted and assigned to IMMUNOMEDICS, INC. on July, 2018 by the United States Patent and Trademark Office.	‌ IMMUNOMEDICS, INC.	‌ IMMUNOMEDICS, INC.	United States Patent and Trademark Office	10034950	July 31, 2018
‌ US Patent 8420783 Method and compositions for immunotherapy of inflammatory and immune-dysregulatory diseases	Patent 8420783 was granted and assigned to IMMUNOMEDICS, INC. on April, 2013 by the United States Patent and Trademark Office.		‌ IMMUNOMEDICS, INC.	United States Patent and Trademark Office	8420783	April 16, 2013
‌ US Patent 9375489 Antibody-SN-38 immunoconjugates with a CL2A linker	Patent 9375489 was granted and assigned to IMMUNOMEDICS, INC. on June, 2016 by the United States Patent and Trademark Office.	‌ IMMUNOMEDICS, INC.	‌ IMMUNOMEDICS, INC.	United States Patent and Trademark Office	9375489	June 28, 2016

...

Results per page:

307 results

0 selected

307 results

0 selected